Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cristina Martínez-Múgica Barbosa"'
Autor:
Carlos Aparicio Carreño, Rubén Pampín Sánchez, Beatriz Fernández González, Cristina Martínez-Múgica Barbosa, Belén Rodríguez de Castro, Francisco Javier Barbazán Vázquez
Publikováno v:
Revista Española de Quimioterapia
espanolObjetivo. Actualmente no existe evidencia clara que guie la dosificacion de cefazolina en pacientes obesos en profilaxis quirurgica. El objetivo fue evaluar la efectividad de este antibiotico con una dosis estandar de 2 g en la prevencion de i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26ff047de8917e6ec77bf452cda556ec
https://doi.org/10.37201/req/026.2020
https://doi.org/10.37201/req/026.2020
Autor:
Arboleya, Sara Rodríguez, Barbosa, Cristina Martínez-Múgica Barbosa, Seoane, María Sagrario Santos, García, Victor Arenas, González, Paula García, González, Josefa Francisca Soler, Martínez, Diego López, Fernández, Claudia Saavedra
Publikováno v:
In Revista clinica espanola November 2023 223 Supplement 2:S794-S795
Autor:
Sonia Tembrás Martinez, Rubén Pampín Sánchez, Cristina Martínez-Múgica Barbosa, Aitor Ayastuy Ruiz, Belén Rodríguez de Castro
Publikováno v:
The International journal of risksafety in medicine. 31(4)
Background: Disease-modifying therapies for multiple sclerosis have been developed tremendously over the last two decades. Objective: The aim of this study was to review the short-, medium-, and long-term safety of alemtuzumab in relapsing remitting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39abbf02da56c675c89c4d303a899b55
https://pubmed.ncbi.nlm.nih.gov/32145001
https://pubmed.ncbi.nlm.nih.gov/32145001
Autor:
Yoar Labeaga Beramendi, Cristina Martínez-Múgica Barbosa, Paloma Terroba Alonso, Javier Barbazán Vázquez, Belén Rodríguez de Castro
Publikováno v:
Eur J Hosp Pharm
Objectives To assess patient satisfaction after pharmacy-mediated replacement of the originator etanercept prefilled syringe with its biosimilar prefilled pen. Methods Prospective observational study from March to May 2018, to assess satisfaction wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9091e793aab77f8b6bcef8fdba3e2af3
https://doi.org/10.1136/ejhpharm-2019-001999
https://doi.org/10.1136/ejhpharm-2019-001999
Autor:
Cristina Martínez-Múgica Barbosa, Aitor Ayastuy Ruiz, Beatriz Fernández González, Belén Rodríguez de Castro
Publikováno v:
Eur J Hosp Pharm
OBJECTIVE: To estimate the risk of progressive multifocal leukoencephalopathy (PML) and the safety of natalizumab administration in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: A descriptive retrospective observational study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad6e79a5f88cf66491ddb1209474272
https://europepmc.org/articles/PMC7907687/
https://europepmc.org/articles/PMC7907687/
